Revenue: The sum of all revenue fields included for a company's operating activities.
Kiniksa Pharmaceuticals, Ltd. (KNSA) had Revenue of $137.78M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$137.78M |
$8.54M |
|
$17.87M |
|
$119.92M |
|
$124.51M |
|
$13.27M |
|
$2.29M |
|
$15.56M |
|
$15.56M |
|
$8.54M |
|
$8.54M |
|
$8.54M |
|
$8.54M |
|
$13.27M |
|
$13.62M |
|
72.65M |
|
76.15M |
|
$0.12 |
|
$0.11 |
|
| Balance Sheet Financials | |
$355.91M |
|
$0.61M |
|
$243.42M |
|
$599.33M |
|
$97.27M |
|
-- |
|
$44.57M |
|
$141.84M |
|
$457.49M |
|
$441.49M |
|
$457.49M |
|
72.80M |
|
| Cash Flow Statement Financials | |
$22.32M |
|
$-51.54M |
|
$2.77M |
|
$183.58M |
|
$157.13M |
|
$-26.45M |
|
$7.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.03% |
|
9.63% |
|
9.63% |
|
-- |
|
11.30% |
|
6.20% |
|
$22.23M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.81 |
|
3.44 |
|
26.17 |
|
1.87% |
|
1.93% |
|
1.42% |
|
1.87% |
|
$6.28 |
|
$0.29 |
|
$0.29 |
|